EULAR/LinkedIn
Dec 18, 2025, 13:16
New Score Quantifying Disease Activity in Patients With Antiphospholipid Syndrome – EULAR
EULAR – European Alliance of Associations for Rheumatology shared a post on LinkedIn:
“NEWS ALERT!
EULAR has developed a new score that quantifies the level of disease activity in people with antiphospholipid syndrome (APS). A key step forward that promises to advance research and improve symptom tracking, both in clinical trials and everyday practice.
Read the full EULAR Press Release here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 19, 2026, 15:54Horace Roman: Sciatic Nerve Endometriosis – Prevent Muscle Atrophy Caused by Progressive Denervation
-
Jun 19, 2026, 15:36Why Does the Clock Read Older? – Fertility Plus
-
Jun 19, 2026, 15:28Asma Khalil: Study Raises Questions About Workplace Activities and Early Pregnancy Outcomes
-
Jun 19, 2026, 15:21Spindle Dynamics and Chromosome Segregation In Human Preimplantation Embryos – Fertility and Sterility
-
Jun 19, 2026, 15:12Today is World Sickle Cell Day – Preeclampsia Foundation
-
Jun 19, 2026, 14:59Marco Zaccaria: ESGE Webinar to Spotlight Advances in the Surgical Management of Parametrial Endometriosis
-
Jun 19, 2026, 14:46PMOS Does Not Make Conception Impossible – PCOS Awareness Association
-
Jun 19, 2026, 14:40Diana Kayal: Successful Fertility Programs Aren’t Built On Clinical Expertise Alone
-
Jun 19, 2026, 14:29Devyanshi Dixit: Call for Abstracts at GFWH 2026